The Genome 360 test is an innovative and advanced genomic clinical interpretation technology designed to provide individuals with valuable health insights. This cutting-edge technology examines a comprehensive set of over 22,000 genes that are specific to each individual. By harnessing the latest DNA sequencing advancements, this test aims to empower individuals in their pursuit of preventing various health conditions such as cancer, heart diseases, diabetes, obesity, and other lifestyle-related disorders.
It is a Next Gen Sequencing (NGS) whole exome test. It follows Illumina sequencer procedures. Proprietary bioinformatics pipelines are used for analysis .ACMG guidelines are followed for data validation. . Only highly significant variants are reported. considered in the final report.
Transform your skincare routine with Derma Care, a game-changer in skin care. Our advanced DNA sequencing test delves into your individual genetic makeup, offering tailored advice to help you improve and maintain your skin well-being. Discover the power of personalized genetic analysis for unlocking your skin’s ultimate health and beauty potential.
Utilizing advanced DNA sequencing and analysis, we leverage your individual genetic composition to offer customized guidance for preventing diseases and delaying the aging process. Anti-aging test presents an encouraging approach for taking proactive control over the aging journey. It allows individuals to effectively oversee the aging process, reduce potential health risks and make informed decisions regarding preventive measures that best suit their needs.
Discover the life-altering potential of Wellness Products as they unveil tailored genetic revelations to enhance your nutritional choices, fitness regimen, and immune system optimization.
This is a Next-Generation Sequencing (NGS) whole exome test. It follows Illumina sequencer guidelines, employs special bioinformatics processing, validates data as per ACMG guidelines, and reports clinically significant variants while considering your medical history and lifestyle.
Epilepsy is a neurological disorder marked by recurring seizures, caused by abnormal brain electrical activity. Seizures result in sudden changes in behavior due to temporary brain function disruption.
Factors like genetic variations, modifier genes, and environmental influences can affect epilepsy susceptibility. To study epilepsy-related genetic variants, we use Whole Exome Sequencing (WES) with Illumina NovaSeq 6000 Next Generation Sequencing (NGS) technology.
We ensure data quality with fastQC and align it to the human reference genome GRCh38.Variant identification follows GATK guidelines. We annotate the genetic variants and assess their clinical significance using Ensemble VEP version 98. Clinical correlations are made for non-synonymous, some synonymous, and splice site variants in the coding region.
We aggregate vast amounts of NGS-based omics data to improve clinical guidance. Our results and reports undergo rigorous review by highly trained researchers with extensive experience.
Introducing Science Quest Nephro Care, the dawn of a revolutionary approach to kidney health management. Our cutting-edge DNA sequencing test delves into your distinct genetic composition, unlocking the potential of your genetic data to deliver tailor-made guidance and tactics for enhancing your kidney health.
Neuromuscular diseases (NMDs) encompass various conditions affecting motor cells, nerves,neuromuscular junctions, or muscles, often due to genetic factors. Common NMD categories include motor neuron diseases, neuropathies, neuromuscular junction diseases, and muscular diseases. We analyze Parkinson’s-associated variants using Whole Exome Sequencing (WES) on Illumina’s NovaSeq 6000, following GATK guidelines, and review results for clinical relevance, ensuring accuracy and guidance.
OncoQuest Comprehensive is an advanced in vitro diagnostic test that employs Next Generation Sequencing (NGS) technology. This cutting-edge test utilizes a highly efficient hybridization-based capture method to analyze DNA obtained from Formalin-Fixed Paraffin Embedded (FFPE) tumor tissue specimens and circulating DNA extracted from peripheral whole blood. It evaluates 351 different genes with a sequencing depth of 3000X, focusing on key aspects such as Homologous Recombination (HRR), programmed death Ligand-1, Microsatellite Instability (MSI), Tumor Mutational Burden (TMB), pharmacogenomics, and nutrigenomics. The scientific foundation supporting this test is built upon the extensive knowledge and expertise of the renowned Memorial Sloan Kettering (MSK) Cancer Center.
OncoQuest, the Condition-Specific Test is an advanced in vitro diagnostic utilizing Next-Generation Sequencing (NGS). This innovative test employs a high-throughput hybridization-based capture technique, targeting both DNA extracted from formalin-fixed paraffin-embedded (FFPE) tumor tissue specimens and circulating DNA from peripheral whole blood. The analysis encompasses a comprehensive range of 16-24 specific genes, with sequencing depths reaching up to an impressive 1000X. The foundation of knowledge for this test is deeply rooted in the expertise of the renowned Memorial Sloan Kettering (MSK) Cancer Center, recognized as the largest and most prominent cancer center worldwide, situated in the United States of America.
Welcome to ScienceQuest Pedia Health, where we’re transforming pediatric healthcare. Our state- of-the-art DNA sequencing test, tailored for kids, harnesses the potential of genetic data to offer customized guidance for enhancing your child’s health. Our committed group of genetic counselors and pediatric experts will assist you in interpreting the findings, equipping you with the information and resources to make informed choices about your child’s well-being.
Discover a new era in reproductive healthcare. Our cutting-edge DNA sequencing test delves you’re your unique genetic profile to offer insights and solutions for your reproductive health. It’s especially valuable for women facing factors like advanced maternal age, consanguinity, infertility, or multiple pregnancy losses. This genetic testing has significant benefits, including pinpointing genetic causes of infertility and enhancing IVF success rates.
Osteoporosis is a bone problem. It makes bones weak and more likely to break. It happens because the balance between breaking down and building up bone is messed up. This makes the bones lose their density. Different things like genes and the environment can make someone more likely to get osteoporosis. To find out if someone has certain gene changes linked to Parkinson’s, we used a method called Whole Exome Sequencing with Illumina’s NovaSeq 6000.We checked the data quality and matched it to the human reference genome GRCh38.We followed guidelines to identify gene changes using GATK.